Summary
A Q&A with Zozan Sewger Kvist, CEO of rare disease competence center grenska, on stalled reform, uneven access to care in Europe and the limits of regulation.
Source: POLITICO.eu
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
